New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents
CA 2426103 A1 · Owner: Robin, Jean-Pierre · Inventors: Robin, Jean-Pierre; Marie, Jean-Pierre; Souchaud, Karine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns a compound of formula (I) wherein: W represents O or NH, Q represents an unbranched or branched saturated or unsaturated or , aromatic cyclic or acyclic or heterocyclic hydrocarboned radical containing 1 to 30 carbon atoms including or not heteroatom(s) R1 is H, OH, OMe, O-(C1-, C30)-alkyl, O-aryl-(C1-C30)-alkyl O-(C2-C30)-alkenyl, O-(C3-C30)-cycloalkyl or and R2 is H or OH, or R1, R2 form together -O- R3=R4=OMe or R3 and R4 , form together -OCH2O- R is H, C1-C30alkyl or O-protecting group and R6 represents an unbranched or branched, saturated or unsaturated or aromatic cyclic or acyclic or heterocyclic hydrocarboned radical containing 1 to 30 carbon …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.